188 related articles for article (PubMed ID: 29937423)
1. Protein-Protein Interaction Network Analysis of Salivary Proteomic Data in Oral Cancer Cases.
Amiri Dash Atan N; Koushki M; Rezaei Tavirani M; Ahmadi NA
Asian Pac J Cancer Prev; 2018 Jun; 19(6):1639-1645. PubMed ID: 29937423
[TBL] [Abstract][Full Text] [Related]
2. Proteomics investigation of OSCC-specific salivary biomarkers in a Hungarian population highlights the importance of identification of population-tailored biomarkers.
Csősz É; Lábiscsák P; Kalló G; Márkus B; Emri M; Szabó A; Tar I; Tőzsér J; Kiss C; Márton I
PLoS One; 2017; 12(5):e0177282. PubMed ID: 28545132
[TBL] [Abstract][Full Text] [Related]
3. Role of Salivary Biomarkers in Oral Cancer Detection.
Khurshid Z; Zafar MS; Khan RS; Najeeb S; Slowey PD; Rehman IU
Adv Clin Chem; 2018; 86():23-70. PubMed ID: 30144841
[TBL] [Abstract][Full Text] [Related]
4. Bioinformatics-Based Identification of Methylated-Differentially Expressed Genes and Related Pathways in Gastric Cancer.
Li H; Liu JW; Liu S; Yuan Y; Sun LP
Dig Dis Sci; 2017 Nov; 62(11):3029-3039. PubMed ID: 28914394
[TBL] [Abstract][Full Text] [Related]
5. Quantitative proteomic analysis for novel biomarkers of buccal squamous cell carcinoma arising in background of oral submucous fibrosis.
Liu W; Zeng L; Li N; Wang F; Jiang C; Guo F; Chen X; Su T; Xu C; Zhang S; Fang C
BMC Cancer; 2016 Aug; 16():584. PubMed ID: 27485544
[TBL] [Abstract][Full Text] [Related]
6. Salivary proteomic analysis of diabetic patients for possible oral squamous cell carcinoma biomarkers.
Jancsik VA; Gelencser G; Maasz G; Schmidt J; Molnar GA; Wittmann I; Olasz L; Mark L
Pathol Oncol Res; 2014 Jul; 20(3):591-5. PubMed ID: 24343817
[TBL] [Abstract][Full Text] [Related]
7. Saliva proteome profiling reveals potential salivary biomarkers for detection of oral cavity squamous cell carcinoma.
Wu CC; Chu HW; Hsu CW; Chang KP; Liu HP
Proteomics; 2015 Oct; 15(19):3394-404. PubMed ID: 26205615
[TBL] [Abstract][Full Text] [Related]
8. Comparison of Salivary and Serum Soluble CD44 Levels between Patients with Oral SCC and Healthy Controls.
Seyedmajidi S; Seyedmajidi M; Foroughi R; Zahedpasha A; Zolfaghari Saravi Z; Pourbagher R; Bijani A; Motallebnejad M; Monfared Shabestani A; Mostafazadeh A
Asian Pac J Cancer Prev; 2018 Nov; 19(11):3059-3063. PubMed ID: 30485941
[TBL] [Abstract][Full Text] [Related]
9. Decreased GRP78 protein expression is a potential prognostic marker of oral squamous cell carcinoma in Taiwan.
Huang TT; Chen JY; Tseng CE; Su YC; Ho HC; Lee MS; Chang CT; Wong YK; Chen HR
J Formos Med Assoc; 2010 May; 109(5):326-37. PubMed ID: 20497865
[TBL] [Abstract][Full Text] [Related]
10. Bioinformatics analysis of aberrantly methylated-differentially expressed genes and pathways in hepatocellular carcinoma.
Sang L; Wang XM; Xu DY; Zhao WJ
World J Gastroenterol; 2018 Jun; 24(24):2605-2616. PubMed ID: 29962817
[TBL] [Abstract][Full Text] [Related]
11. Label-free plasma proteomics for the identification of the putative biomarkers of oral squamous cell carcinoma.
Gautam SS; Singh RP; Karsauliya K; Sonker AK; Reddy PJ; Mehrotra D; Gupta S; Singh S; Kumar R; Singh SP
J Proteomics; 2022 May; 259():104541. PubMed ID: 35231661
[TBL] [Abstract][Full Text] [Related]
12. Gene expression profiling via bioinformatics analysis reveals biomarkers in laryngeal squamous cell carcinoma.
Guan GF; Zheng Y; Wen LJ; Zhang DJ; Yu DJ; Lu YQ; Zhao Y; Zhang H
Mol Med Rep; 2015 Aug; 12(2):2457-64. PubMed ID: 25936657
[TBL] [Abstract][Full Text] [Related]
13. S100A8 as potential salivary biomarker of oral squamous cell carcinoma using nanoLC-MS/MS.
Jou YJ; Hua CH; Lin CD; Lai CH; Huang SH; Tsai MH; Kao JY; Lin CW
Clin Chim Acta; 2014 Sep; 436():121-9. PubMed ID: 24863804
[TBL] [Abstract][Full Text] [Related]
14. Salivary Immunosuppressive Cytokines IL-10 and IL-13 Are Significantly Elevated in Oral Squamous Cell Carcinoma Patients.
Aziz S; Ahmed SS; Ali A; Khan FA; Zulfiqar G; Iqbal J; Khan AA; Shoaib M
Cancer Invest; 2015; 33(7):318-28. PubMed ID: 26046681
[TBL] [Abstract][Full Text] [Related]
15. Aberrant proteins in the saliva of patients with oral squamous cell carcinoma.
Jessie K; Jayapalan JJ; Ong KC; Abdul Rahim ZH; Zain RM; Wong KT; Hashim OH
Electrophoresis; 2013 Sep; 34(17):2495-502. PubMed ID: 23784731
[TBL] [Abstract][Full Text] [Related]
16. Identification of breast cancer hub genes and analysis of prognostic values using integrated bioinformatics analysis.
Fang E; Zhang X
Cancer Biomark; 2017 Dec; 21(1):373-381. PubMed ID: 29081411
[TBL] [Abstract][Full Text] [Related]
17. S100A7 overexpression is a predictive marker for high risk of malignant transformation in oral dysplasia.
Kaur J; Matta A; Kak I; Srivastava G; Assi J; Leong I; Witterick I; Colgan TJ; Macmillan C; Siu KW; Walfish PG; Ralhan R
Int J Cancer; 2014 Mar; 134(6):1379-88. PubMed ID: 24122701
[TBL] [Abstract][Full Text] [Related]
18. Proteomics-based identification of haptoglobin as a novel plasma biomarker in oral squamous cell carcinoma.
Lai CH; Chang NW; Lin CF; Lin CD; Lin YJ; Wan L; Sheu JJ; Chen SY; Huang YP; Sing YT; Tao TW; Lai CK; Tsai MH; Chan HL; Jou YJ; Lin CW
Clin Chim Acta; 2010 Jul; 411(13-14):984-91. PubMed ID: 20359475
[TBL] [Abstract][Full Text] [Related]
19. A Bayesian Network-based approach for discovering oral cancer candidate biomarkers.
Kourou K; Exarchos KP; Papaloukas C; Fotiadis DI
Annu Int Conf IEEE Eng Med Biol Soc; 2015; 2015():7663-6. PubMed ID: 26738067
[TBL] [Abstract][Full Text] [Related]
20. Identification of hub subnetwork based on topological features of genes in breast cancer.
Zhuang DY; Jiang L; He QQ; Zhou P; Yue T
Int J Mol Med; 2015 Mar; 35(3):664-74. PubMed ID: 25573623
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
